Overview

Comparative Effectiveness Study for Bipolar Disorder

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness of lithium and quetiapine for the treatment of individuals with bipolar disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Agency for Healthcare Research and Quality (AHRQ)
Treatments:
Lithium Carbonate
Quetiapine Fumarate